Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004122 |
---|---|
Receipt number | R000004902 |
Scientific Title | Randomized phase II study of oxaliplatin reintroduction and the biweekly XELOX in previously treated patients with metastatic colorectal cancer (ORION study) |
Date of disclosure of the study information | 2010/09/01 |
Last modified on | 2018/09/20 08:22:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/08/29 13:03:25 | ||
2 | Update | 2010/09/28 22:17:14 | Public title |
|
3 | Update | 2010/10/08 16:36:18 | Public title Acronym |
|
4 | Update | 2010/10/08 16:37:58 | Key exclusion criteria |
|
5 | Update | 2011/08/05 19:39:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2012/04/04 09:30:35 | Recruitment status |
|
7 | Update | 2012/06/08 10:38:01 | Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Name of person sending information Organization Organization Division name Division name Address Address TEL Email1 |
|
8 | Update | 2012/08/29 12:57:02 | Email |
|
9 | Update | 2013/09/01 17:33:39 | Email Last name of contact person Last name of contact person Address |
|
10 | Update | 2015/10/19 09:46:08 | Recruitment status Publication of results Results |
|
11 | Update | 2015/11/18 12:26:52 | Recruitment status Results Other related information |
|
12 | Update | 2016/04/04 16:01:52 | Name of primary person or sponsor Organization |
|
13 | Update | 2018/09/20 08:22:33 | Recruitment status |